THE FIRST large real-life trial of COVID-19 positive patients at increased risk of severe illness for two types of monoclonal antibody infusions showed reduced severity of their infection compared to controls.
Tuesday, 21 September 2021
Covid breakthrough: First real-life trial of antibodies – reduce hospitalisations by 70%
THE FIRST large real-life trial of COVID-19 positive patients at increased risk of severe illness for two types of monoclonal antibody infusions showed reduced severity of their infection compared to controls.
0 comments:
Post a Comment